摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

((1R,2R,3R,4S,5S)-4-amino-2,3,5-trihydroxycyclohexyl)methyl dihydrogen phosphate | 1301234-92-3

中文名称
——
中文别名
——
英文名称
((1R,2R,3R,4S,5S)-4-amino-2,3,5-trihydroxycyclohexyl)methyl dihydrogen phosphate
英文别名
(1S,2S,3R,4R,5R)-2-amino-5-((phosphonooxy)methyl)cyclohexane-1,3,4-triole;(1S,2S,3R,4R,5R)-2-amino-5-((phosphonooxy)methyl)-cyclohexane-1,3,4-triol;[(1R,2R,3R,4S,5S)-4-amino-2,3,5-trihydroxycyclohexyl]methyl dihydrogen phosphate
((1R,2R,3R,4S,5S)-4-amino-2,3,5-trihydroxycyclohexyl)methyl dihydrogen phosphate化学式
CAS
1301234-92-3
化学式
C7H16NO7P
mdl
——
分子量
257.18
InChiKey
GCWCTHQYELYNOQ-VOQCIKJUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -6.2
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    154
  • 氢给体数:
    6
  • 氢受体数:
    8

反应信息

点击查看最新优质反应信息

文献信息

  • CYCLOHEXANE COMPOUNDS AND THEIR USE AS ANTIBIOTICS
    申请人:UNIVERSITÄT KONSTANZ
    公开号:US20140066409A1
    公开(公告)日:2014-03-06
    The present invention relates to compounds according to general formula (I), pharmaceutical compositions comprising compounds according to general formula (I) and the use of the compounds for the treatment of a bacterial infection, particularly for use as an antibiotic.
    本发明涉及符合通用式(I)的化合物,包括符合通用式(I)的化合物的制药组合物以及该化合物用于治疗细菌感染,特别是用作抗生素的用途。
  • Cyclohexane compounds and their use as antibiotics
    申请人:Mayer Günter
    公开号:US08846645B2
    公开(公告)日:2014-09-30
    The present invention relates to compounds according to general formula (I), pharmaceutical compositions comprising compounds according to general formula (I) and the use of the compounds for the treatment of a bacterial infection, particularly for use as an antibiotic.
    本发明涉及符合一般式(I)的化合物、包含符合一般式(I)的化合物的药物组合物以及用于治疗细菌感染的化合物的用途,特别是用作抗生素。
  • [EN] CYCLOHEXANE COMPOUNDS AND THEIR USE AS ANTIBIOTICS<br/>[FR] COMPOSÉS CYCLOHEXANE ET LEUR UTILISATION EN TANT QU'ANTIBIOTIQUES
    申请人:UNIV BONN
    公开号:WO2012080240A1
    公开(公告)日:2012-06-21
    The present invention relates to compounds according to general formula (I), pharmaceutical compositions comprising compounds according to general formula (I) and the use of the compounds for the treatment of a bacterial infection, particularly for use as an antibiotic.
    本发明涉及一般式(I)的化合物,包括该化合物的制药组合物以及该化合物用于治疗细菌感染,特别是用作抗生素的用途。
  • US8846645B2
    申请人:——
    公开号:US8846645B2
    公开(公告)日:2014-09-30
  • Synthesis and evaluation of glucosamine-6-phosphate analogues as activators of glmS riboswitch
    作者:Guan-Nan Wang、Pui Sai Lau、Yingfu Li、Xin-Shan Ye
    DOI:10.1016/j.tet.2012.09.015
    日期:2012.11
    The glmS riboswitch is a ribozyme found in numerous Gram-positive bacteria and responds to the cellular concentrations of glucosamine 6-phosphate (GlcN6P). Given the importance of GlcN6P for cell wall biosynthesis, the glmS riboswitch has become a new drug target for the development of antibiotics. Herein, we describe the efficient synthesis of three GlcN6P analogues and their evaluation on inducing self-cleavage of the glmS riboswitch from Bacillus subtilis. Our results provide valuable information for further elucidation of the structure activity relationships and drug design for glmS riboswitch antibiotics. (C) 2012 Elsevier Ltd. All rights reserved.
查看更多